Gilenya Cuts in Fall 2014

Quote
Anonymous said:
I Forgot about some of those mistakes. Don't call it a pill. Isn't that it's top selling point?The FDO fiasco proved management was outmatched and came from primary care background. My favorite was just get SRFs don't worry about pull through. How many physicians still talk about those patients where it took 4 -6 months to get on drug if they were started at all. 3 1/2 years later and 10% market share. Embarrassing
Click to expand...

You know the launch history all too well. Another misfired NVS launch. Remember you ONlY get one shot to launch a drug and you need competent mgmt to do it right. Gilenya will always be step child in MS market........ Right up until until mgmt decides it's time to hold the sales force accountable for their mistakes and sends them through the chop shop.
 




Anonymous said:
You know the launch history all too well. Another misfired NVS launch. Remember you ONlY get one shot to launch a drug and you need competent mgmt to do it right. Gilenya will always be step child in MS market........ Right up until until mgmt decides it's time to hold the sales force accountable for their mistakes and sends them through the chop shop.
Click to expand...

Of course. The combo of Gilenya pathetic mgmt and Biogen eating our lunch, sales force moral is very low right now.
 




The Bold contest got me fired up. The chance to win 300 bucks to TJ Max makes me wanna work really hard. The drug is 50K a year and this is the dumb contest you come up who thinks of this shit. The Teva reps are still making more bonus then us.
 




Anonymous said:
The Bold contest got me fired up. The chance to win 300 bucks to TJ Max makes me wanna work really hard. The drug is 50K a year and this is the dumb contest you come up who thinks of this shit. The Teva reps are still making more bonus then us.[/

Difficult to move any drug when incompetent mgmt screwed the launch up. Primary care business plan models with check the box mentalities will continue to put us furtherand further behind the competition.
Click to expand...
 




It's over we are a 10% market share drug unless Tecfidera gets PML. Leadership blew another launch all the meetings,contests,segmentation won't change anything. I am only here because there is not much out there.
 




Anonymous said:
It's over we are a 10% market share drug unless Tecfidera gets PML. Leadership blew another launch all the meetings,contests,segmentation won't change anything. I am only here because there is not much out there.
Click to expand...

Leadership problems: They still think a primary care model sells a specialty drug. Fact: 3 1/2 years after launch and it is PROVEN the Novartis primary care model doesn't work.

Fact: Micro management and reach and frequency are not what moves market share. Clinical discussions and partnering with the dr's who write MS drugs moves market share. The primary care ABLS and RBDs still don't understand.

Fact: Sales team is checked out but little opportunity elsewhere. Why would Novartis management team enforce a non compete and want to hold on to employees that wish to leave. The employee doesn't want to work here and the employee stays and does a poor job.

There is no reason to continue to try to teach these idiots how to do their job. The PC mentality will not change and the 10% market share is here to stay. BTW - Management hates the 10% market share that is why they discuss the billion dollar drug. If we had the Techfidera market share that would be the 1st part Gilenya's success story
 




Anonymous said:
Leadership problems: They still think a primary care model sells a specialty drug. Fact: 3 1/2 years after launch and it is PROVEN the Novartis primary care model doesn't work.

Fact: Micro management and reach and frequency are not what moves market share. Clinical discussions and partnering with the dr's who write MS drugs moves market share. The primary care ABLS and RBDs still don't understand.

Fact: Sales team is checked out but little opportunity elsewhere. Why would Novartis management team enforce a non compete and want to hold on to employees that wish to leave. The employee doesn't want to work here and the employee stays and does a poor job.

There is no reason to continue to try to teach these idiots how to do their job. The PC mentality will not change and the 10% market share is here to stay. BTW - Management hates the 10% market share that is why they discuss the billion dollar drug. If we had the Techfidera market share that would be the 1st part Gilenya's success story
Click to expand...

Dude, you spelled it out pretty dang close to reality.
 
























There will be no layoffs in MSBU any time soon. Established Medicines yes. But MSBU? Nah...

Fact 1. In 2015 Gilenya will get PPMS inducation, the only DMT with such an indication
Fact 2. In 2016 Gilenya will get CIPD indication
Fact 3. According to March 2014 settlement, Gilenya has patent protection through 2019
Fact 4. Novartis launching new molecule for MS in 2018
Fact 5. MSBU has less than 110 reps in the entire country. Very lean already.

So please quit spreading fears. You are in Specialty. Act like it! Yes we are micromanaged and leaders came from Primary Care. So they believe in reach and frequency. So what? Find another job making a base of 125k and bonus of 25-45k depending on performance, 75k bonus if you are in top 7 percent. You guys have it good. If this is a Biogen rep then enjoy your 3 person cluster while it lasts, how many Tec patients are you guys losing per month due to Diarrhea?
 




Anonymous said:
There will be no layoffs in MSBU any time soon. Established Medicines yes. But MSBU? Nah...

Fact 1. In 2015 Gilenya will get PPMS inducation, the only DMT with such an indication
Fact 2. In 2016 Gilenya will get CIPD indication
Fact 3. According to March 2014 settlement, Gilenya has patent protection through 2019
Fact 4. Novartis launching new molecule for MS in 2018
Fact 5. MSBU has less than 110 reps in the entire country. Very lean already.

So please quit spreading fears. You are in Specialty. Act like it! Yes we are micromanaged and leaders came from Primary Care. So they believe in reach and frequency. So what? Find another job making a base of 125k and bonus of 25-45k depending on performance, 75k bonus if you are in top 7 percent. You guys have it good. If this is a Biogen rep then enjoy your 3 person cluster while it lasts, how many Tec patients are you guys losing per month due to Diarrhea?
Click to expand...

If you had any pride you would be embarrassed by a 10% market share. Does mirco management work? Does reach and frequency work in a specialty sale? 10% MARKET SHARE AT 3 1/2 YEARS ANSWERS THESE QUESTIONS.
 




Anonymous said:
If you had any pride you would be embarrassed by a 10% market share. Does mirco management work? Does reach and frequency work in a specialty sale? 10% MARKET SHARE AT 3 1/2 YEARS ANSWERS THESE QUESTIONS.
Click to expand...

Don't post the exception to the rule base pay of 125k. Several NVS internals switched over here as a lateral. That's right 0 increase in base pay. Most don't make above 80k base and this is fact. NVS looking to save money by bringing PCP internals over. They are also used to the PCP mgmt style.
 




Anonymous said:
There will be no layoffs in MSBU any time soon. Established Medicines yes. But MSBU? Nah...

Fact 1. In 2015 Gilenya will get PPMS inducation, the only DMT with such an indication
Fact 2. In 2016 Gilenya will get CIPD indication
Fact 3. According to March 2014 settlement, Gilenya has patent protection through 2019
Fact 4. Novartis launching new molecule for MS in 2018
Fact 5. MSBU has less than 110 reps in the entire country. Very lean already.

So please quit spreading fears. You are in Specialty. Act like it! Yes we are micromanaged and leaders came from Primary Care. So they believe in reach and frequency. So what? Find another job making a base of 125k and bonus of 25-45k depending on performance, 75k bonus if you are in top 7 percent. You guys have it good. If this is a Biogen rep then enjoy your 3 person cluster while it lasts, how many Tec patients are you guys losing per month due to Diarrhea?
Click to expand...

Finally someone with a head posting on this thread. I agree! Both MS and Onc are the safest places to be both at Novartis and Industry wide. Derm too much of an unknown. Serelaxin dead. Established Meds is anything but. Alcon just had layoffs again. MS and Onc are the only good places right now
 




Anonymous said:
Finally someone with a head posting on this thread. I agree! Both MS and Onc are the safest places to be both at Novartis and Industry wide. Derm too much of an unknown. Serelaxin dead. Established Meds is anything but. Alcon just had layoffs again. MS and Onc are the only good places right now
Click to expand...

PPMS indication? yeah just like the cognition approval.
 




Anonymous said:
Finally someone with a head posting on this thread. I agree! Both MS and Onc are the safest places to be both at Novartis and Industry wide. Derm too much of an unknown. Serelaxin dead. Established Meds is anything but. Alcon just had layoffs again. MS and Onc are the only good places right now
Click to expand...

Somebody is responding to their own post here. Come on pal..... That is way weak!
 




Anonymous said:
Finally someone with a head posting on this thread. I agree! Both MS and Onc are the safest places to be both at Novartis and Industry wide. Derm too much of an unknown. Serelaxin dead. Established Meds is anything but. Alcon just had layoffs again. MS and Onc are the only good places right now
Click to expand...

With the industry loosing 40% of reps jobs over the last few years that isn't saying much.
 




Anonymous said:
Biogen is just worried about the email sent to every KOL about a sex scandal. Stay classy Biogen
Click to expand...

and you think that sex scandals don't happen at NVS? open you eyes. Many males in senior positions routinely try to pick up associates within the company. Look, you're talking about Gilenya, look no further than the leadership managing this product!
If many of the senior staff were located in countries where woman have actual equal rights, there would a load of sexual harassment cases within this company.
But god forbid you talk to HR about this - they will cover the asses of the senior managers SO quickly and ensure that every last bit of it get's swept under the rug.
 




Top Bottom
Back
Quote